Inhibition of DNA‑PK by gefitinib causes synergism between gefitinib and cisplatin in NSCLC

Jianjin Huang(Second Affiliated Hospital of Zhejiang University)
International Journal of Oncology
July 27, 2020
Cited by 5


Related Papers